BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26056787)

  • 1. Atypical Clinical Course in Pediatric Hodgkin Lymphoma: Association With Germline Mutations in Interleukin-2-inducible T-Cell Kinase.
    Alme C; Satwani P; Alobeid B; Bhagat G; Kelly KM
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):507-8. PubMed ID: 26056787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
    Bienemann K; Borkhardt A; Klapper W; Oschlies I
    Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?
    Ghosh S; Drexler I; Bhatia S; Adler H; Gennery AR; Borkhardt A
    Front Immunol; 2018; 9():979. PubMed ID: 29867957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
    Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
    Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma.
    Youssefian L; Vahidnezhad H; Yousefi M; Saeidian AH; Azizpour A; Touati A; Nikbakht N; Hesari KK; Adib-Sereshki MM; Zeinali S; Mansoori B; Jazayeri A; Karamzadeh R; Fortina P; Jouanguy E; Casanova JL; Uitto J
    Clin Infect Dis; 2019 May; 68(11):1938-1941. PubMed ID: 30778533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases.
    Linka RM; Risse SL; Bienemann K; Werner M; Linka Y; Krux F; Synaeve C; Deenen R; Ginzel S; Dvorsky R; Gombert M; Halenius A; Hartig R; Helminen M; Fischer A; Stepensky P; Vettenranta K; Köhrer K; Ahmadian MR; Laws HJ; Fleckenstein B; Jumaa H; Latour S; Schraven B; Borkhardt A
    Leukemia; 2012 May; 26(5):963-71. PubMed ID: 22289921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease.
    Yufu Y; Kimura M; Kawano R; Noguchi Y; Takatsuki H; Uike N; Ohshima K
    Bone Marrow Transplant; 2000 Dec; 26(12):1339-41. PubMed ID: 11223975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach.
    Stepensky P; Weintraub M; Yanir A; Revel-Vilk S; Krux F; Huck K; Linka RM; Shaag A; Elpeleg O; Borkhardt A; Resnick IB
    Haematologica; 2011 Mar; 96(3):472-6. PubMed ID: 21109689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.
    Basso S; Zecca M; Calafiore L; Rubert L; Fiocchi R; Paulli M; Quartuccio G; Guido I; Sebastiani R; Croci GA; Beschi C; Nardiello I; Ginevri F; Cugno C; Comoli P
    Pediatr Transplant; 2013 Nov; 17(7):E168-73. PubMed ID: 23992468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
    Huck K; Feyen O; Niehues T; Rüschendorf F; Hübner N; Laws HJ; Telieps T; Knapp S; Wacker HH; Meindl A; Jumaa H; Borkhardt A
    J Clin Invest; 2009 May; 119(5):1350-8. PubMed ID: 19425169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.
    Elsayed AA; Asano N; Ohshima K; Izutsu K; Kinoshita T; Nakamura S
    Pathol Int; 2014 Jul; 64(7):336-45. PubMed ID: 25047504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I associations with EBV+ post-transplant lymphoproliferative disorder.
    Jones K; Wockner L; Thornton A; Gottlieb D; Ritchie DS; Seymour JF; Kumarasinghe G; Gandhi MK
    Transpl Immunol; 2015 Mar; 32(2):126-30. PubMed ID: 25731678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target.
    Tse E; Kwong YL
    Exp Mol Med; 2015 Jan; 47(1):e136. PubMed ID: 25613733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients.
    Kojima M; Motoori T; Nakamura S
    Biomed Pharmacother; 2006 Dec; 60(10):663-72. PubMed ID: 17064872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodeficiency-related Hodgkin lymphoma and its mimics.
    Said JW
    Adv Anat Pathol; 2007 May; 14(3):189-94. PubMed ID: 17452815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated lymphoproliferative disorder presenting with classical Hodgkin lymphoma and developing as peripheral T-cell lymphoma 9 years later: a case report of composite lymphoma.
    Oka K; Nagayama R; Iijima S; Yonekawa N; Hirosawa K; Yatabe Y; Mori N
    Pathol Int; 2011 Dec; 61(12):752-5. PubMed ID: 22126384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.